跳转至内容
Merck

Y0000481

Dibrompropamidine for system suitability

European Pharmacopoeia (EP) Reference Standard

别名:

Dibrompropamidine diisetionate

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C21H30Br2N4O10S2
CAS号:
分子量:
722.42
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

dibrompropamidine

製造商/商標名

EDQM

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-8°C

InChI

1S/C17H18Br2N4O2.C2H6O4S/c18-12-8-10(16(20)21)2-4-14(12)24-6-1-7-25-15-5-3-11(17(22)23)9-13(15)19;3-1-2-7(4,5)6/h2-5,8-9H,1,6-7H2,(H3,20,21)(H3,22,23);3H,1-2H2,(H,4,5,6)

InChI 密鑰

BZACJASHKPPTKX-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Dibrompropamidine for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Allergic contact dermatitis from dibrompropamidine cream.
C Lützow-Holm
Contact dermatitis, 20(2), 160-160 (1989-02-01)
Teresa Løvold Berents et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 129(4), 305-307 (2009-02-24)
There is a high incidence of traumatic wounds. Such wounds often become infected which prolongs the wound healing process. Many patients will contact a pharmacy for antiseptic treatment. Various over-the-counter drugs can help as antiseptic treatment; Brulidine is a cream
Cosmetic contact lens-related Acanthamoeba keratitis.
James McKelvie et al.
Clinical & experimental ophthalmology, 37(4), 419-420 (2009-07-15)
P Wright et al.
The British journal of ophthalmology, 69(10), 778-782 (1985-10-01)
The first medical cure of a corneal infection due to an Acanthamoeba species is reported. The 44-year-old patient developed a suppurative keratitis associated with an epithelial defect, hypopyon, and secondary glaucoma. Acanthamoeba was confirmed as the causative agent four months
N A Turner et al.
The Journal of antimicrobial chemotherapy, 46(1), 27-34 (2000-07-07)
A synchronous encystment method was used to study the order of development of resistance of Acanthamoeba castellanii to a range of biocides. The emerging resistance during encystation to short-term exposure to the minimum amoebicidal concentrations of each biocide tested was

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门